Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apremilast for Rheumatoid Arthritis Treatment
NCT01250548Phase 2Completed
- Sponsor
- Baylor Scott & White Research Institute
- Start
- May 2010
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of apremilast in rheumatoid arthritis (RA), sponsored by Baylor Scott & White Research Institute. Started May 2010; status: completed.
02
Drugs
apremilast
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01250548.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01250548.